Research Highlights Preventable Pneumococcal Infections as Major Cause of Adult Pneumonia Hospitalizations

A groundbreaking study highlights the significant role of preventable pneumococcal infections in adult pneumonia hospitalizations, emphasizing the need for enhanced vaccination strategies and diagnostic methods to reduce disease burden.
A recent multicenter study conducted across hospitals in Tennessee and Georgia, including Vanderbilt University Medical Center, has shed light on the significant impact of pneumococcal infections on adult pneumonia hospitalizations. The research analyzed data from 2018 to 2022, utilizing a novel serotype-specific urinary test capable of identifying 30 different strains of Streptococcus pneumoniae, a bacteria responsible for various pneumonia cases.
The study distinguished community-acquired pneumonia (CAP), which occurs outside healthcare settings, from hospital-acquired pneumonia, emphasizing the importance of prevention in community settings. Researchers found that approximately 14% of the 340 annual hospitalizations for CAP per 100,000 adults involved infections caused by Streptococcus pneumoniae.
One notable aspect of this research was the identification of noninvasive pneumococcal infections, which are often missed with traditional diagnostic methods like blood cultures. The more sensitive urinary antigen test revealed numerous pneumococcal infections that would have otherwise gone undetected, highlighting a potentially larger burden of disease.
The findings estimate that annually, about 114,800 adults in the U.S. are hospitalized due to pneumococcal pneumonia, predominantly among older populations. Experts from the study, including Dr. Carlos Grijalva, emphasize that Streptococcus pneumoniae remains a key cause of severe community-acquired pneumonia.
Furthermore, many of the identified serotypes are covered by a newly licensed adult pneumococcal vaccine, V116, which includes 21 strains. Although this vaccine was not available during the study, its broader coverage could significantly reduce pneumonia-related hospitalizations, especially among seniors.
Researchers advocate for expanded vaccination strategies to target additional pneumococcal serotypes, which could play a critical role in decreasing the severity and occurrence of pneumonia in adults.
This study underscores the continuing importance of pneumococcal vaccination and improved diagnostic methods to prevent and manage pneumonia cases effectively.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding Parkinson's Disease: Symptoms, Diagnosis, and Management
Learn about the complex symptoms, diagnostic methods, and treatment options for Parkinson's disease, a progressive neurodegenerative disorder affecting movement and beyond.
New Biologic Treatment Significantly Improves Outcomes in Severe Pulmonary Hypertension
A groundbreaking clinical trial shows that early use of sotatercept, a biologic drug, significantly reduces symptoms and hospitalizations in patients with severe pulmonary arterial hypertension, promising improved outcomes and earlier intervention benefits.
HIV Testing and Outreach Decline Amid Funding Cuts in the Southern U.S.
Federal funding cuts in the South threaten to derail progress in HIV testing, prevention, and treatment, risking increased infections and health disparities among vulnerable populations.



